Vitamin D for Preeclampsia
(PROVIDE Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to explore how vitamin D might reduce inflammation linked to preeclampsia (a condition during pregnancy marked by high blood pressure and swelling) and postpartum depression (depression after childbirth). It also examines how early mental health screening and education can help pregnant women lower the risk of postpartum depression. The study is open to pregnant women in their third trimester who are patients at Cedars-Sinai Medical Center in Los Angeles. Participants will engage in a mental health screening and education program.
As an unphased trial, this study offers participants the chance to contribute to important research that could enhance maternal health and well-being.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this mental health screening, education, and referral program is safe?
Research shows that vitamin D is generally safe for people. Most studies find serious side effects to be rare. Some individuals might experience minor issues like a mild stomach upset, but this is uncommon. The FDA has approved vitamin D for other uses, indicating its safety for most people.
The mental health program in this trial does not involve medication, so participants will not experience physical side effects. They will learn about mental health, which can be beneficial.
Overall, current research and past studies consider the treatments in this trial safe.
Why are researchers excited about this trial?
Unlike traditional treatments for preeclampsia, which often involve medication to manage blood pressure and prevent seizures, this approach focuses on a mental health screening, education, and referral program. Researchers are excited about this trial because it explores the potential impact of mental health and education interventions on pregnancy outcomes. By addressing mental health and providing education, this approach aims to improve overall maternal health, potentially reducing the incidence or severity of preeclampsia. This could lead to a broader understanding of how holistic care impacts pregnancy, offering new pathways for managing the condition beyond just medication.
What evidence suggests that this mental health screening program is effective for reducing postpartum depression?
Studies have shown that education and counseling programs can positively affect pregnant women at risk of preeclampsia. Research indicates that these programs help women adopt healthier lifestyle habits, even if they don't directly lower the risk of preeclampsia. One study found that counseling improved women's knowledge and awareness about preeclampsia. In this trial, all participants will receive a mental health screening, education, and referral intervention. These findings suggest that such programs might support healthier pregnancies and could also help with related conditions, like postpartum depression.12345
Who Is on the Research Team?
Eynav Accortt, PhD
Principal Investigator
Cedars Sinai Medical Center Department of OBGYN
Are You a Good Fit for This Trial?
This trial is for pregnant women aged 18 or older, patients at Cedars Sinai Medical Center in Los Angeles, between 20-40 weeks of gestation (mainly recruited at the start of the third trimester), who prefer English or Spanish.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive mental health screening, education, and referral intervention
Follow-up
Participants are monitored for safety and effectiveness after treatment, including postpartum assessments at 4 weeks and 3 months
What Are the Treatments Tested in This Trial?
Interventions
- Mental Health Screening, Education and Referral Program
Find a Clinic Near You
Who Is Running the Clinical Trial?
Cedars-Sinai Medical Center
Lead Sponsor
Maternal Mental Health NOW
Collaborator